Preimplantation Genetic Diagnosis (胚胎植入前基因診斷): Understanding PGD Technology

Wiki Article

Preimplantation genetic diagnosis (胚胎植入前基因診斷) is a reproductive genetic procedure that allows embryos created through IVF to be examined for specific genetic disorders before implantation. It was one of the earliest forms of embryo genetic testing and was developed to help families affected by known inherited conditions.

The main purpose of preimplantation genetic diagnosis is to identify whether embryos carry specific disease-causing genetic changes. This may allow individuals with a known risk of transmitting inherited disorders to consider reproductive options with additional genetic information.

The process begins with IVF, where eggs and sperm are combined in a laboratory to create embryos. After early embryo development, specialists collect cells from embryos and analyze them for specific genetic mutations associated with particular inherited conditions.

Preimplantation genetic diagnosis differs from general chromosome screening because it focuses on known genetic conditions rather than broad chromosome evaluation. For example, it may be considered by families with a history of certain single-gene disorders.

The use of preimplantation genetic diagnosis requires careful medical and genetic counseling. Healthcare professionals discuss the purpose of testing, possible results, limitations, and ethical considerations before treatment decisions are made.

Modern reproductive genetics has expanded significantly since the introduction of 胚胎植入前基因診斷. Today, embryo testing technologies provide individuals with more information and options when planning pregnancies while managing potential genetic risks.